Improving the care for HIV-infected prisoners: An integrated prison-release health model

Public Health Behind Bars: From Prisons to Communities

Volumn , Issue , 2007, Pages 535-555

  Springer, Sandra A ^a   Altice, Frederick L ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77955920534     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-0-387-71695-4_30     Document Type: Chapter

References (78)

1. Altice, F., & Khoshnood, K. (1997). Transitional case management as a strategy for linking HIV-infected prisoners to community health and social services (Project TLC). Paper presented at the Connecticut Department of Public Heath.
2. Altice, F., Mezger, J. A., Hodges, J., Bruce, R. D., Marinovich, A., Walton, M., et al. (2004). Developing a directly administered antiretroviral therapy intervention for HIV-infected drug users: Implications for program replication. Clin Infect Dis, 38(Suppl. 5), S376-387.
3. Altice, F. L., Friedland, G. H., & Cooney, E. L. (1999). Nevirapine induced opiate withdrawal among injection drug users with HIV infection receiving methadone. AIDS, 13, 957-962.
4. Altice, F. L., Mostashari, F., Selwyn, P. A., Checko, P. J., Singh, R., Tanguay, S., et al. (1998). Predictors of HIV infection among newly sentenced male prisoners. J Acquir Immune Defic Syndr Hum Retrovirol, 18, 444-453.
5. Altice, F. L., Smith-Rohrberg, D., Bruce, R. D., Springer, S., & Friedland, G. (2007). Superiority of directly administered antiretroviral therapy compared to self-administered therapy among HIV-infected drug users enrolled in a six-month prospective, randomized controlled trial. JAMA, in press.
6. Altice, F. L., Springer, S., Buitrago, M., Hunt, D. P., & Friedland, G. H. (2003). Pilot study to enhance HIV care using needle exchange-based health services for out-oftreatment injecting drug users. J Urban Health, 80, 416-427.
7. Babudieri, S., Aceti, A., D'Offizi, G. P., Carbonara, S., & Starnini, G. (2000). Directly observed therapy to treat HIV infection in prisoners. JAMA, 284, 179-180.
8. Badger, D., Vaughan, P., Woodward, M., & Williams, P. (1999). Planning to meet the needs of offenders with mental disorders in the United Kingdom. Psychiatr Serv, 50, 1624-1627.
9. Beck, A., Karberg, J., & Harrison, P. (2002). Prison and jail inmates at midyear 2001.Retrieved from http://www.ojp.usdoj.gov/bjs/pub/pdf/pjim01.pdf.
10. Bouhnik, A. D., Chesney M., Carrieri, P., Gallais, H. et al. (2002). Nonadherence among HIV-infected injecting drug users: the impact of social instability. JAIDS 31, Supp 3, S149-153. Retrieved from http://www.ojp.usdoj. gov/bjs/pub/pdf/satsfp97.pdf
11. Bruce, R. D., Altice, F. L., Gourevitch, M. N., & Friedland, G. H. (2006). Pharmacokinetic drug interactions between opioid agonist therapy and antiretroviral medications: Implications and management for clinical practice. J Acquir Immune Defic Syndr, 41, 563-572.
12. Carrieri, M. P., Chesney, M. A., Spire, B., Loundou, A., Sobel, A., Lepeu, G., et al. (2003). Failure to maintain adherence to HAART in a cohort of French HIV-positive injecting drug users. Int J Behav Med, 10, 1-14.
13. CDC. (1999). Decrease in AIDS-related mortality in a state correctional system - New York, 1995-1998. MMWR, 47(51-52), 1115-1117.
14. CDC. (2001). Helping inmates return to the community. Retrieved 2004 from www.cdc.gov/idu.
15. Cloutier, G. (2002, July 7-21). Strategies to support treatment adherence in newly released HIV-positive prisoners. Paper presented at the XIV International AIDS Conference, Barcelona, Spain.
16. Conklin, T. J., Lincoln, T., & Flanigan, T. P. (1998). A public health model to connect correctional health care with communities. Am J Public Health, 88, 1249-1250.
17. Crosland, C., Poshkus, M., & Rich, J. D. (2002). Treating prisoners with HIV/AIDS: The importance of early identification, effective treatment, and community followup. AIDS Clin Care, 14(8), 67-71, 76.
18. Daar, E. S., Cohen, C., Remien, R., Sherer, R., & Smith, K. (2003). Improving adherence to antiretroviral therapy. AIDS Read, 13(2), 81-82, 85-86, 88-90.
19. Dolan, K., Hall, W., & Wodak, A. (1996). Methadone maintenance reduces injecting in prison. BMJ, 312, 1162.
20. Durand, E. (2001). [Changes in high-dose buprenorphine maintenance therapy at the Fleury-Merogis (France) prison since 1996]. Ann Med Interne (Paris), 152 (Suppl. 7), 9-14.
21. Estebanez, P., Zunzunegui, M. V., Aguilar, M. D., Russell, N., Cifuentes, I., & Hankins, C. (2002). The role of prisons in the HIV epidemic among female injecting drug users. AIDS Care, 14, 95-104.
22. Feder, L. (1991). A comparison of the community adjustment of mentally ill offenders with those from general population: An 18-month follow-up. Law Hum Behav, 15, 477-493.
23. Fischl, M., Castro, J., & Monroig, R. (2001). Impact of directly observed therapy on long-term outcomes in HIV clinical trials. Paper presented at the 8th Conference on Retroviruses and Opportunistic Infections, Alexandria, VA.
24. Flanigan, T. P., Kim, J. Y., Zierler, S., Rich, J., Vigilante, K., & Bury-Maynard, D. (1996). A prison release program for HIV-positive women: Linking them to health services and community follow-up. Am J Public Health, 86, 886-887.
25. Glaser, J. B., & Greifinger, R. B. (1993). Correctional health care: A public health opportunity. Ann Intern Med, 118, 139-145.
26. Grinstead, O., Zack, B., & Faigeles, B. (2001). Reducing postrelease risk behavior among HIV seropositive prison inmates: The health promotion program. AIDS Educ Prev, 13, 109-119.
27. Hammett, T. M., Harmon, M. P., & Rhodes, W. (2002). The burden of infectious disease among inmates of and releasees from US correctional facilities, 1997. Am J Public Health, 92, 1789-1794.
28. Holmes, L., Drainoni, M., & Rich, J. (2002, July). Harm reduction focused case management for multiply diagnosed HIV-positive ex-offenders. Paper presented at the XIV International AIDS Conference, Barcelona, Spain.
29. Homebase, P. (2006). Retrieved April 3, 2006, from www.sph.emory.edu/ HIVCDP/ california.htm.
30. Hubbard, M. (2002, July). The effect of discharge planning on health outcomes for HIV-infected prison inmates. Paper presented at the XIV International AIDS Conference, Barcelona, Spain.
31. Kaplowitz, L., Kaatz, J., & Weir-Wiggins, C. (2002, July). Seamless transition of HIV+ inmates into community care in Virginia. Paper presented at the XIV International AIDS Conference, Barcelona, Spain.
32. Karberg, J., & James, D. (2005). Substance dependence, abuse, and treatment of jail inmates, 2002 (No. NCJ 209588). Washington, DC.
33. Khalsa, J., Genser, S., Vocci, F., Francis, H., & Bean, P. (2002). The challenging interactions between antiretroviral agents and addiction drugs. Am Clin Lab, 21(3), 10-13.
34. Kiefer, F., & Mann, K. (2005). New achievements and pharmacotherapeutic approaches in the treatment of alcohol dependence. Eur J Pharmacol, 526(1-3), 163-171.
35. Kozal, M. J., Amico, K. R., Chiarella, J., Cornman, D., Fisher, W., Fisher, J., et al. (2005). HIV drug resistance and HIV transmission risk behaviors among active injection drug users. J Acquir Immune Defic Syndr, 40, 106-109.
36. Kushel, M. B., Colfax, G., Ragland, K., Heineman, A., Palacio, H., & Bangsberg, D. R. (2006). Case management is associated with improved antiretroviral adherence and CD4+ cell counts in homeless and marginally housed individuals with HIV infection. Clin Infect Dis, 43, 234-242.
37. Laufer, F., Arriola, K., & Dawson-Rose, C. (2002). From jail to community: Innovative strategies to enhance continutity of HIV/AIDS care. The Prison Journal, 82, 84-100.
38. Levasseur, L., Marzo, J., Ross, N., & Blatier, C. (2002). Frequency of re-incarcerations in the same detention center: Role of substitution therapy. A preliminary retrospective analysis. Ann Med Interne, 153(3 Suppl.), 1S14-19.
39. Linder, J. F., Enders, S. R., Craig, E., Richardson, J., & Meyers, F. J. (2002). Hospice care for the incarcerated in the United States: An introduction. J Palliat Med, 5, 549-552.
40. Longshore, D., Hsieh, S. C., & Anglin, M. D. (1994). Reducing HIV risk behavior among injection drug users: Effect of methadone maintenance treatment on number of sex partners. Int J Addict, 29, 741-757.
41. Lovell, D., Gagliardi, G. J., & Peterson, P. D. (2002). Recidivism and use of services among persons with mental illness after release from prison. Psychiatr Serv, 53, 1290-1296.
42. Lucas, G. M., Gebo, K. A., Chaisson, R. E., & Moore, R. D. (2002). Longitudinal assessment of the effects of drug and alcohol abuse on HIV-1 treatment outcomes in an urban clinic. AIDS, 16, 767-774.
43. Lucas, G. M., Mullen, B. A., Weidle, P. J., Hader, S., McCaul, M. E., & Moore, R. D. (2006). Directly administered antiretroviral therapy in methadone clinics is associated with improved HIV treatment outcomes, compared with outcomes among concurrent comparison groups. Clin Infect Dis, 42, 1628-1635.
44. Magura, S., Rosenblum, A., Lewis, C., & Joseph, H. (1993). The effectiveness of in-jail methadone maintenance. J Drug Issues, 23, 75-99.
45. Margolis, A. D., MacGowan, R. J., Grinstead, O., Sosman, J., Kashif, I., & Flanigan, T. P. (2006). Unprotected sex with multiple partners: Implications for HIV prevention among young men with a history of incarceration. Sex Transm Dis, 33, 175-180.
46. Mason, B. J. (2003). Acamprosate and naltrexone treatment for alcohol dependence: An evidence-based risk-benefits assessment. Eur Neuropsychopharmacol, 13, 469-475.
47. Mattick, R., Ali, R., & White, J. (2002). Buprenorphine versus methadone maintenance therapy: A randomized double-blind trial with 405 opioid-dependent patients. Addiction, 98, 441-452.
48. Mumola, C. (1999). Substance abuse and treatment, state and federal prisoners, 1997.Retrieved from
49. Retrieved from Nelles, J., & Harding, T. (1995). Preventing HIV transmission in prison: A tale of medical disobedience and Swiss pragmatism. Lancet, 346, 1507-1508.
50. Palepu, A., Horton, N. J., Tibbetts, N., Meli, S., & Samet, J. H. (2004). Uptake and adherence to highly active antiretroviral therapy among HIV-infected people with alcohol and other substance use problems: The impact of substance abuse treatment. Addiction, 99, 361-368.
51. Palepu, A., Tyndall, M. W., Li, K., Yip, B., O'Shaughnessy, M. V., Schechter, M. T., et al. (2003). Alcohol use and incarceration adversely affect HIV-1 RNA suppression among injection drug users starting antiretroviral therapy. J Urban Health, 80, 667-675.
52. Pollard, R. B. (2002). Can HIV infection be treated successfully with a once-daily regimen? AIDS Read, 12(11), 489-490, 494-498, 500, 508.
53. Rich, J. D., Holmes, L., Salas, C., Macalino, G., Davis, D., Ryczek, J., et al. (2001).Successful linkage of medical care and community services for HIV-positive offenders being released from prison. J Urban Health, 78, 279-289.
54. Richie, B. E., Freudenberg, N., & Page, J. (2001). Reintegrating women leaving jail into urban communities: A description of a model program. J Urban Health, 78, 290-303.
55. Roozen, H. G., de Waart, R., van der Windt, D. A., van den Brink, W., de Jong, C. A., & Kerkhof, A. J. (2006). A systematic review of the effectiveness of naltrexone in the maintenance treatment of opioid and alcohol dependence. Eur Neuropsychopharmacol, 16, 311-323.
56. Schottenfeld, R. S., Pakes, J. R., Oliveto, A., Ziedonis, D., & Kosten, T. R. (1997).Buprenorphine vs methadone maintenance treatment for concurrent opioid dependence and cocaine abuse. Arch Gen Psychiatry, 54, 713-720.
57. Shuter, J. (2002). Communicable diseases in inmates; public health opportunities. Paper presented at the Health Status of Soon-to-be-Released Inmates. Sibbald, B. (2002). Methadone maintenance expands inside federal prisons. CMAJ, 167, 1154.
58. Smith-Rohrberg, D., & Altice, F. L. (2006). Randomized, controlled trials of directly administered antiretroviral therapy for HIV-infected patients: Questions about study population and analytical approach. Clin Infect Dis, 43, 1221-1222; author reply 1222-1223.
59. Smith-Rohrberg, D., Bruce, R. D., & Altice, F. L. (2004). Review of corrections-based therapy for opiate-dependent patients: Implications for buprenorphine treatment among correctional populations. J Drug Issues, 34, 451-480.
60. Smith-Rohrberg, D., Kozal, M. J., Springer, S., & Altice, F. L. (submitted). Similar Rates of Genotypic Resistance Among HIV-Infected Drug Users Receiving Directly Administered Antiretroviral Therapy and Self-Administered Therapy: Results from a Six-Month Prospective, Randomized Controlled Trial. Unpublished Journal Article. Yale School of Medicine, Yale AIDS Program.
61. Smith-Rohrberg, D., Mezger, J., Walton, M., Bruce, R. D., & Altice, F. L. (2006).Impact of enhanced services on virologic outcomes in a directly administered antiretroviral therapy trial for HIV-infected drug users. J Acquir Immune Defic Syndr Hum Retrovirol, 43(Suppl. 1), S48-53.
62. Sosman, J., Baker, J., & Catz, S. (2002). Clinical and immune recovery during antiretroviral therapy among HIV-infected prisoners. Paper presented at the XIV International AIDS Conference, Barcelona, Spain.
63. Spaulding, A., Stephenson, B., Macalino, G., Ruby, W., Clarke, J. G., & Flanigan, T. P. (2002). Human immunodeficiency virus in correctional facilities: A review. Clin Infect Dis, 35, 305-312.
64. Springer, S. A., & Altice, F. L. (2005). Managing HIV/AIDS in correctional settings. Curr HIV/AIDS Rep, 2, 165-170.
65. Springer, S. A., Pesanti, E., Hodges, J., Macura, T., Doros, G., & Altice, F. L. (2004). Effectiveness of antiretroviral therapy among HIV-infected prisoners: Reincarceration and the lack of sustained benefit after release to the community. Clin Infect Dis, 38, 1754-1760.
66. Stein, M. D., Solomon, D. A., Herman, D. S., Anderson, B. J., & Miller, I. (2003).Depression severity and drug injection HIV risk behaviors. Am J Psychiatry, 160, 1659-1662.
67. Stephenson, B. L., Wohl, D. A., Golin, C. E., Tien, H. C., Stewart, P., & Kaplan, A. H. (2005). Effect of release from prison and re-incarceration on the viral loads of HIV-infected individuals. Public Health Rep, 120, 84-88.
68. Stephenson, B. L., Wohl, D. A., McKaig, R., Golin, C. E., Shain, L., Adamian, M., et al. (2006). Sexual behaviours of HIV-seropositive men and women following release from prison. Int J STD AIDS, 17, 103-108.
69. Theall, K., Clark, R., Powell, A., Smith, H., & Kissinger, P. (2006). Alcohol consumption, art usage and high-risk sex among women infected with HIV [Electronic Version]. AIDS and Behavior. Retrieved September 18, 2006.
70. Thompson, A. S., Blankenship, K. M., Selwyn, P. A., Khoshnood, K., Lopez, M., Balacos, K., et al. (1998). Evaluation of an innovative program to address the health and social service needs of drug-using women with or at risk for HIV infection. J Community Health, 23, 419-440.
71. Tomasino, V., Swanson, A. J., Nolan, J., & Shuman, H. I. (2001). The Key Extended Entry Program (KEEP): A methadone treatment program for opiate-dependent inmates. Mt Sinai J Med, 68, 14-20.
72. Tucker, J. S., Burnam, M. A., Sherbourne, C. D., Kung, F. Y., & Gifford, A. L. (2003).Substance use and mental health correlates of nonadherence to antiretroviral medications in a sample of patients with human immunodeficiency virus infection. Am J Med, 114, 573-580.
73. Turner, B. J., Fleishman, J. A., Wenger, N., London, A. S., Burnam, M. A., Shapiro, M. F., et al. (2001). Effects of drug abuse and mental disorders on use and type of antiretroviral therapy in HIV-infected persons. J Gen Intern Med, 16, 625-633.
74. Tyndall, M. W., Patrick, D., Spittal, P., Li, K., O'Shaughnessy, M. V., & Schechter, M. T. (2002). Risky sexual behaviours among injection drugs users with high HIV prevalence: Implications for STD control. Sex Transm Infect, 78(Suppl. 1), i170-175.
75. WHO. (1993). World Health Organization guidelines on HIV infection and AIDS in prison. Strasbourg: Council of Europe: Ministers of the State Members.
76. Williams, S. H. (2005). Medications for treating alcohol dependence. Am Fam Physician, 72, 1775-1780.
77. Wohl, A. R., Garland, W. H., Valencia, R., Squires, K., Witt, M. D., Kovacs, A., et al. (2006). A randomized trial of directly administered antiretroviral therapy and adherence case management intervention. Clin Infect Dis, 42, 1619-1627.
78. Wolff, N. (2005). Community reintegration of prisoners with mental illness: A social investment perspective. Int J Law Psychiatry, 28, 43-58.